Tenet director sells 5,638 shares in open trade

Tenet Healthcare director J. Robert Kerrey reported open-market sales of company common stock.

Rhea-AI Filing Summary

Tenet Healthcare director J. Robert Kerrey reported open-market sales of company common stock. On May 28, 2026, he sold a total of 5,638 shares in multiple transactions at weighted average prices within ranges from $172.63 to $178.08 per share, as detailed in the footnotes. After these sales, he directly owns 16,804 shares of Tenet Healthcare common stock.

Insider Trade Summary

Net Seller: 5,638 shares

Net Sell 5 txns

Insider KERREY J ROBERT

Role Director

Sold 5,638 shs ($984K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,969	$173.12	$341K
Sale	Common Stock	1,690	$173.97	$294K
Sale	Common Stock	713	$175.13	$125K
Sale	Common Stock	905	$176.89	$160K
Sale	Common Stock	361	$177.52	$64K

Holdings After Transaction: Common Stock — 16,804 shares (Direct)

Footnotes (5)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $172.63 to $173.60.
2. F2. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $173.69 to $174.37.
3. F3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $174.92 to $175.69.
4. F4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $176.21 to $177.20.
5. F5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $177.25 to $178.08.

Key Figures

Shares sold: 5,638 shares Post-sale holdings: 16,804 shares Highest reported sale price: $178.08 per share +2 more

5 metrics

Shares sold 5,638 shares Total common stock sold on May 28, 2026

Post-sale holdings 16,804 shares Common stock directly owned after transactions

Highest reported sale price $178.08 per share Upper end of disclosed price ranges

Lowest reported sale price $172.63 per share Lower end of disclosed price ranges

Number of sale transactions 5 transactions Open-market sales of common stock

Key Terms

open-market sale, weighted average sales price, Form 4, Common Stock, +1 more

5 terms

open-market sale financial

"transaction_action: "open-market sale" for each common stock transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sales price financial

"The price is the weighted average sales price of the aggregate number of shares..."

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

beneficially owned financial

"total_shares_following_transaction" ... total shares beneficially owned following the transaction"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Tenet Healthcare (THC) disclose for J. Robert Kerrey?

Tenet Healthcare disclosed that director J. Robert Kerrey sold 5,638 shares of common stock in open-market transactions on May 28, 2026. These trades were reported on Form 4 and involved multiple price ranges as described in the filing footnotes.

How many Tenet Healthcare (THC) shares did the director sell and at what prices?

The director sold 5,638 shares of Tenet Healthcare common stock across five open-market transactions. Weighted average sale prices correspond to ranges from $172.63 to $178.08 per share, with specific ranges detailed for each tranche in the Form 4 footnotes.

How many Tenet Healthcare (THC) shares does the director still hold after the sale?

After completing the reported sales, J. Robert Kerrey directly holds 16,804 shares of Tenet Healthcare common stock. This post-transaction ownership figure is shown in the Form 4 as the total shares beneficially owned following the last reported sale.

Were the Tenet Healthcare (THC) insider trades open-market sales or another type of transaction?

All reported transactions were open-market sales of Tenet Healthcare common stock. The Form 4 lists transaction code “S” and describes each as a sale in the open market or a private transaction, with no derivative exercises or gifts reported.

Did the Tenet Healthcare (THC) Form 4 include any derivative securities transactions?

The Form 4 shows no derivative securities transactions for this reporting period. All five entries involve non-derivative common stock, and the derivativeSummary section is empty, indicating no option exercises, conversions, or other derivative activity were reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 08:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERREY J ROBERT

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		S		1,969	D	$173.12(1)	20,473	D
Common Stock	05/28/2026		S		1,690	D	$173.97(2)	18,783	D
Common Stock	05/28/2026		S		713	D	$175.13(3)	18,070	D
Common Stock	05/28/2026		S		905	D	$176.89(4)	17,165	D
Common Stock	05/28/2026		S		361	D	$177.52(5)	16,804	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $172.63 to $173.60.

2. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $173.69 to $174.37.

3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $174.92 to $175.69.

4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $176.21 to $177.20.

5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $177.25 to $178.08.

	Chad J. Wiener, as Attorney-in-Fact for J. Robert Kerrey	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)